| review article | Q7318358 |
| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P819 | ADS bibcode | 2013PLoSO...873398W |
| P356 | DOI | 10.1371/JOURNAL.PONE.0073398 |
| P932 | PMC publication ID | 3751870 |
| P698 | PubMed publication ID | 24009750 |
| P5875 | ResearchGate publication ID | 256452920 |
| P50 | author | Molly S Rosenberg | Q57010248 |
| P2093 | author name string | Daniel Westreich | |
| Sheree Schwartz | |||
| Geeta Swamy | |||
| P2860 | cites work | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement | Q56530014 |
| Pregnancy and HIV Disease Progression during the Era of Highly Active Antiretroviral Therapy | Q58055138 | ||
| Young peopleʼs sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey | Q59153647 | ||
| Pregnancy and virologic response to antiretroviral therapy in South Africa | Q28741879 | ||
| Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals | Q30397298 | ||
| Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients | Q30399281 | ||
| A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine | Q33448696 | ||
| Inclusion of women in clinical trials | Q33509625 | ||
| Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study | Q33531746 | ||
| Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial | Q33665210 | ||
| Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression | Q34115025 | ||
| High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa | Q34257078 | ||
| Screening for acute HIV infection in South Africa: finding acute and chronic disease. | Q34268037 | ||
| Representation of elderly persons and women in published randomized trials of acute coronary syndromes | Q34331421 | ||
| Incidence of pregnancy after initiation of antiretroviral therapy in South Africa: a retrospective clinical cohort analysis | Q34331885 | ||
| Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy | Q34332659 | ||
| Cervicovaginal Shedding of HIV Type 1 Is Related to Genital Tract Inflammation Independent of Changes in Vaginal Microbiota | Q34553877 | ||
| The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women | Q34591725 | ||
| Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa | Q34624904 | ||
| Baseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: the role of patient autonomy and fatalistic religious beliefs | Q34627306 | ||
| Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults | Q34699094 | ||
| Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen | Q34699201 | ||
| The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone | Q34731327 | ||
| Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine | Q34732952 | ||
| Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics | Q34774846 | ||
| Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa | Q35165313 | ||
| Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples | Q35214337 | ||
| Pregnancy incidence and outcomes in vertically and behaviorally HIV-infected youth | Q35657221 | ||
| HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study | Q35686969 | ||
| Pharmacokinetics of antiretrovirals in pregnant women | Q35965780 | ||
| Relative time to pregnancy among HIV-infected and uninfected women in the Women's Interagency HIV Study, 2002-2009 | Q36395038 | ||
| The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics | Q36468109 | ||
| Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial | Q37201300 | ||
| Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine | Q37351372 | ||
| Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone | Q37393366 | ||
| Responding to her question: a review of the influence of pregnancy on HIV disease progression in the context of expanded access to HAART in sub-Saharan Africa | Q37419150 | ||
| After inclusion, information and inference: reporting on clinical trials results after 15 years of monitoring inclusion of women | Q37889293 | ||
| Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe | Q38878179 | ||
| Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study | Q38880362 | ||
| Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model | Q39588459 | ||
| High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy | Q39741284 | ||
| Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection | Q43651001 | ||
| The role of mannose-binding lectin gene polymorphisms in susceptibility to HIV-1 infection in Southern Brazilian patients | Q44234277 | ||
| Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients | Q44349455 | ||
| The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis | Q46357608 | ||
| Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. | Q46806431 | ||
| A randomized crossover study to compare efavirenz and etravirine treatment | Q48331724 | ||
| Enrolling pregnant women in biomedical research | Q48872267 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human pregnancy | Q11995 |
| pregnant women | Q308623 | ||
| systematic review | Q1504425 | ||
| medical research | Q2752427 | ||
| human immunodeficiency virus infectious disease | Q18556697 | ||
| RNA virus infectious disease | Q18967413 | ||
| Retroviridae infectious disease | Q19000689 | ||
| pregnant person | Q104720811 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e73398 | |
| P577 | publication date | 2013-08-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Representation of women and pregnant women in HIV research: a limited systematic review | |
| P478 | volume | 8 |
| Q33691429 | A qualitative study on acceptable levels of risk for pregnant women in clinical research |
| Q39525139 | Advancing HIV research with pregnant women: navigating challenges and opportunities |
| Q47547028 | Facilitators and barriers to pregnant women's participation in research: A systematic review |
| Q38567814 | Fertility-related research needs among women at the margins |
| Q39280374 | HIV Risk Reduction Interventions Among Substance-Abusing Reproductive-Age Women: A Systematic Review |
| Q35908984 | How do outcomes compare between women and men living with HIV in Australia? An observational study. |
| Q90348296 | Screening and Enrollment by Sex in HIV Clinical Trials in the United States |
| Q46187732 | Viraemia before, during and after pregnancy in HIV-infected women on antiretroviral therapy in rural KwaZulu-Natal, South Africa, 2010-2015. |
| Q35953569 | Women in HIV cure research: multilevel interventions to improve sex equity in recruitment |
Search more.